Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt · Delayed Price · Currency is EGP 1,258.26
-44.89 (-3.44%)
At close: Oct 22, 2026
EGX:AXPH Balance Sheet
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 397.14 | 285.8 | 150.04 | 90.51 | 153.75 |
Cash & Short-Term Investments | 397.14 | 285.8 | 150.04 | 90.51 | 153.75 |
Cash Growth | 38.96% | 90.49% | 65.77% | -41.13% | 194.98% |
Accounts Receivable | 249.45 | 120.65 | 62.7 | 66.91 | 113.61 |
Other Receivables | 87.38 | 95.44 | 87.2 | 28.14 | 22.65 |
Receivables | 404.49 | 265.29 | 186.19 | 144.18 | 168.13 |
Inventory | 538.4 | 607.36 | 522.51 | 345.41 | 271.51 |
Prepaid Expenses | 0.19 | 0.19 | 0.19 | 0.27 | 0.36 |
Restricted Cash | - | - | - | - | 0 |
Other Current Assets | - | -0 | -0 | -0 | 0 |
Total Current Assets | 1,340 | 1,159 | 858.93 | 580.36 | 593.76 |
Property, Plant & Equipment | 433.1 | 366 | 379.71 | 340.24 | 279.06 |
Long-Term Investments | 2.39 | 2.39 | 2.39 | 2.39 | 2.39 |
Other Long-Term Assets | - | -0 | - | -0 | - |
Total Assets | 1,776 | 1,527 | 1,241 | 922.99 | 875.21 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 323.42 | 309.36 | 277.85 | 139.28 | 160.86 |
Accrued Expenses | 6.04 | 6.07 | 5.17 | 4.16 | 4.32 |
Short-Term Debt | 9.74 | 4.08 | 0.81 | 12.03 | 9.11 |
Current Unearned Revenue | 0.38 | 0.61 | 0.24 | 1.25 | - |
Other Current Liabilities | 248.63 | 203.67 | 152.4 | 91.7 | 78.13 |
Total Current Liabilities | 588.23 | 523.8 | 436.47 | 248.42 | 252.43 |
Long-Term Deferred Tax Liabilities | 8.32 | 8.95 | 9.57 | 14.44 | 10.18 |
Total Liabilities | 596.54 | 532.75 | 446.04 | 262.85 | 262.6 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 50 | 50 | 50 | 50 | 50 |
Retained Earnings | 1,122 | 936.98 | 738.24 | 604.42 | 494.73 |
Comprehensive Income & Other | 7.3 | 7.3 | 6.74 | 5.72 | 67.87 |
Shareholders' Equity | 1,179 | 994.28 | 794.98 | 660.14 | 612.6 |
Total Liabilities & Equity | 1,776 | 1,527 | 1,241 | 922.99 | 875.21 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 9.74 | 4.08 | 0.81 | 12.03 | 9.11 |
Net Cash (Debt) | 387.4 | 281.72 | 149.22 | 78.48 | 144.63 |
Net Cash Growth | 37.51% | 88.79% | 90.14% | -45.74% | 187.27% |
Net Cash Per Share | 68.59 | 52.47 | 29.84 | 15.70 | 28.93 |
Filing Date Shares Outstanding | 5 | 5 | 5 | 5 | 5 |
Total Common Shares Outstanding | 5 | 5 | 5 | 5 | 5 |
Working Capital | 752 | 634.85 | 422.46 | 331.94 | 341.33 |
Book Value Per Share | 235.83 | 198.86 | 159.00 | 132.03 | 122.52 |
Tangible Book Value | 1,179 | 994.28 | 794.98 | 660.14 | 612.6 |
Tangible Book Value Per Share | 235.83 | 198.86 | 159.00 | 132.03 | 122.52 |
Land | 0.08 | - | - | - | - |
Buildings | 197.44 | - | - | - | - |
Machinery | 490.81 | - | - | - | - |
Construction In Progress | 140.35 | - | - | - | - |